Childress Capital Advisors, LLC Dexcom Inc Transaction History

Childress Capital Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 24, 2024	BUY	$114.22 - $140.1 $169,959 - $208,468	1,488 New	1,488 $206,000
Q4 2022 Feb 03, 2023	BUY	$84.98 - $122.67 $179,477 - $259,079	2,112 New	2,112 $239,000
Q1 2021 May 21, 2021	SELL	$84.79 - $104.74 $26,369 - $32,574	-311 Closed	0 $0
Q4 2020 Mar 09, 2021	BUY	$78.0 - $104.5 $24,258 - $32,499	311 New	311 $114,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Childress Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Childress Capital Advisors, LLC with notifications on news.